acute myeloid leukemia (AML) | Page 45 | Aplastic Anemia & MDS International Foundation Return to top.

acute myeloid leukemia (AML)

Valeria Santini, MD

Santini, Valeria
Associate Professor
University of Florence

Valeria Santini is an Associate Professor of Hematology at the University of Florence Medical School in Florence Italy, where she received her degree in Medicine and Postgraduate diploma in hematology (cum laude). She worked as an EORTC fellow in experimental hematology from 1988 to 1991 at the Dr. den Hoed Kliniek, Erasmus University, Rotterdam. In 1999 she worked in the Department of Leukemia at MD Anderson Cancer Center, University of Texas, Houston.

Shyamala Navada, MD

Navada, Shyamala
Associate Professor of Medicine, Hematology and Medical Oncology
Mount Sinai Medical Center

Dr. Navada is an assistant professor in the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York City.  She attended medical school at the University of Illinois at Chicago.  Subsequently, she did an Internal Medicine Residency at the University of Michigan in Ann Arbor prior to completing a hematology/oncology fellowship at Mount Sinai.  She is currently completing a Masters of Science in

Timothy Graubert, MD

Graubert, Timothy
Director, Hematologic Malignancies Program, Hagler Family Chair in Oncology, Professor of Medicine
Massachusetts General Hospital, Harvard Medical School

Dr. Graubert’s research focuses on the molecular pathogenesis of myeloid leukemias. While at Washington University in St. Louis, he and his colleagues used genome sequencing technology extensively to gain insights into the genetic basis of human cancer and to use this information to improve risk stratification tools and identify targets for novel therapy.  Their group published the first complete genome sequence of a human cancer (

B. Douglas Smith, MD

Smith, B. Douglas
Professor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University

B. Douglas Smith is Professor of Oncology at Johns Hopkins University School of Medicine in Baltimore, Maryland, and is on the active staff of Johns Hopkins Hospital. He earned his medical degree at the Medical College of Pennsylvania in Philadelphia, after which he completed an internship, residency, and chief residency at Strong Memorial Hospital in Rochester, New York.  At the completion of his fellowship in Oncology at Johns Hopkins University, he joined the faculty in the Division of Hematologic Malignancies. 

Michael Keng, MD

Keng, Michael
Assistant Professor, Division of Hematology/Oncology
University of Virginia Cancer Center

Dr. Michael Keng holds a clinical faculty appointment in Medicine in the Division of Hematology/Oncology at UVA Cancer Center. He practices at the Emily Couric Clinical Cancer Center in Charlottesville and serves as an inpatient hematologist at UVA Hospital.

Share with addtoany.com.